semaglutide ema Novo Nordisk Submits 7.2 mg Wegovy to for Obesity Treatment | Paramesh Shamanna posted on the topic Europe allows Novo to include

However, as we enter the era of GLP-1 medications (like Semaglutide and Tirzepatide), the conversation is changing

Meanwhile, patients in the United States are suing Novo Nordisk for not telling them that Ozempic could cause them to develop blindness (NAION), pancreatitis, ileus, or gastroparesis

Are you looking to lose weight and are B12 deficient

While GLP-1 and GIP receptor agonists modulate appetite and glucose regulation and show benefits in NASH, earlier agents have no direct effect on the liver fibrosis seen in more advanced disease

Reconstitution technique matters more than most users initially realize

They are complementary, not interchangeable